mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.2 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |